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Abstract
Background: Habitual consumption of xylitol reduces mutans streptococci (MS) levels but the effect on
Lactobacillus spp. is less clear. Reduction is dependent on daily dose and frequency of consumption. For
xylitol to be successfully used in prevention programs to reduce MS and prevent caries, effective xylitol
delivery methods must be identified. This study examines the response of MS, specifically S. mutans/sobrinus
and Lactobacillus spp., levels to xylitol delivered via gummy bears at optimal exposures.
Methods: Children, first to fifth grade (n = 154), from two elementary schools in rural Washington State,
USA, were randomized to xylitol 15.6 g/day (X16, n = 53) or 11.7 g/day (X12, n = 49), or maltitol 44.7 g/
day (M45, n = 52). Gummy bear snacks were pre-packaged in unit-doses, labeled with ID numbers, and
distributed three times/day during school hours. No snacks were sent home. Plaque was sampled at
baseline and six weeks and cultured on modified Mitis Salivarius agar for S. mutans/sobrinus and Rogosa SL
agar for Lactobacillus spp. enumeration.
Results: There were no differences in S. mutans/sobrinus and Lactobacillus spp. levels in plaque between
the groups at baseline. At six weeks, log10 S. mutans/sobrinus levels showed significant reductions for all
groups (p = 0.0001): X16 = 1.13 (SD = 1.65); X12 = 0.89 (SD = 1.11); M45 = 0.91 (SD = 1.46). Reductions
were not statistically different between groups. Results for Lactobacillus spp. were mixed. Group X16 and
M45 showed 0.31 (SD = 2.35), and 0.52 (SD = 2.41) log10 reductions, respectively, while X12 showed a
0.11 (SD = 2.26) log10 increase. These changes were not significant. Post-study discussions with school staff
indicated that it is feasible to implement an in-classroom gummy bear snack program. Parents are accepting
and children willing to consume gummy bear snacks daily.
Conclusion: Reductions in S. mutans/sobrinus levels were observed after six weeks of gummy bear snack
consumption containing xylitol at 11.7 or 15.6 g/day or maltitol at 44.7 g/day divided in three exposures.
Lactobacillus spp. levels were essentially unchanged in all groups. These results suggest that a xylitol gummy
bear snack may be an alternative to xylitol chewing gum for dental caries prevention. Positive results with
high dose maltitol limit the validity of xylitol findings. A larger clinical trial is needed to confirm the xylitol
results.
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Background
Mutans streptococci (MS), more specifically S. mutans and
S. sobrinus, are implicated in the development of dental
caries in humans [1]. Xylitol, a naturally occurring sugar
alcohol approved for use in food by the U.S. Food and
Drug Administration (FDA) since 1963, has been shown
to reduce MS levels in plaque and saliva and to markedly
reduce tooth decay. Studies involving schoolchildren
demonstrated that habitual use decreased dental caries.
A recent review summarized the availability of xylitol-con-
taining products on the internet and in supermarkets and
other commercial outlets in the U.S. and included an
assessment of their potential to provide a minimally effec-
tive dose (6 g) to reduce MS and tooth decay [2]. The
review reports that, aside from chewing gum and loz-
enges, there have been few clinical studies performed on
other xylitol-containing products. In all, the existing stud-
ies suggested that xylitol can reduce MS levels in saliva and
plaque and reduce tooth decay. However, these prospec-
tive trials were not designed to assess the relationship
between dose or frequency of xylitol use and reductions in
MS level or tooth decay. To fill this gap, our group con-
ducted studies to determine the minimal effective dose [3]
and frequency [4] of xylitol use when delivered via chew-
ing gum. These studies concluded that xylitol chewing
gum dose of 6.9 to 10.3 g divided into at least three uses
per day is efficacious in reducing MS, specifically S. mutans
and S. sobrinus (herein referred to as S. mutans/sobrinus),
level in plaque and saliva. On the other hand, 3.4 g/day or
frequencies of use less than 3 times/day were not statisti-
cally different from controls even though small reductions
were observed.
Xylitol chewing gum and lozenges are widely available
and used by consumers in Europe and in Korea, Japan,
Thailand, and China. Finland was the first country to
implement a national campaign, "Smart Habits" xylitol,
to promote xylitol use to reduce tooth decay in children
[5]. Similar promotions are occurring in other European
and Asian countries especially Japan and Korea where xyl-
itol chewing gum has captured nearly 50% of the chewing
gum market. More recently, the U.S. Army implemented
the "Look for Xylitol First" initiative to promote xylitol
use among deployed troops to improve their oral health
[6] and have begun to include xylitol chewing gum in
"meals ready to eat" (MRE) rations. Similar programs to
address tooth decay in U.S. children have not been
adopted in part because chewing gum and hard candies
consumption are considered choking hazards and thus
not acceptable xylitol delivery vehicles for children [7].
For xylitol to be successfully used in oral health preven-
tion programs for U.S. children, effective means of deliv-
ering xylitol in a therapeutic dose and frequency must be
identified.
The purpose of this RCT was to test the hypothesis that six
weeks of habitual consumption of a xylitol gummy bear
snack is effective in reducing S. mutans/sobrinus in plaque
and to lay the groundwork for a dental caries trial. This
study also evaluated the effect of xylitol on Lactobacillus
spp.
Methods
Subjects
Subjects (n = 154) were first to fifth grade children attend-
ing Morton and White Pass elementary schools in rural
Washington State, USA. The children were initially pre-
sented a skit with an oral health message during a general
assembly to introduce them to the University of Washing-
ton research team. A partnership between the research
team and each school was established. The school sent
parents an informational letter describing the study and
asked permission for their child's participation in the
"Gummy Bear Study" (see Additional file 1). Parents
interested in having their children participate signed and
returned the enclosed consent form along with a brief
general health questionnaire (see Additional file 2). Chil-
dren with reported antibiotic use during the previous two
weeks or anticipated its use during the study period were
excluded, as were children with a history of gastrointesti-
nal problems. At the first study visit, the assent of each
child was obtained prior to study procedures. The Univer-
sity of Washington Institutional Review Board approved
the study and related materials.
Study design
This prospective double-blind, randomized trial
employed a three-group design. Children received either
15.6 g (X16) or 11.7 g (X12) xylitol/day, or maltitol
(M45) 44.7 g/day. Maltitol was used as the null-compari-
son because it is only slowly fermentable and a previous
study reported no adaptation by MS in plaque to maltitol
or xylitol compared to sorbitol and sucrose [8]. Because
the gummy bears might be hastily chewed, resulting in
small chunks which then would be swallowed thus reduc-
ing the xylitol oral bioavailability, higher xylitol doses
were used than in previous gum or lozenges studies.
The study design controlled for the frequency and number
of gummy bears consumed. Dose of xylitol was varied by
combining xylitol and maltitol gummy bears. Pre-pack-
aged and labeled gummy bear unit-doses were distributed
in the classroom during school hours three times per day.
Gummy bears were not sent home on non-school or
missed school days. Subjects were randomly assigned to
groups using a computer generated block randomization
procedure to ensure a similar proportion of participants
in each group. The group assignments were kept by the
biostatistician and were decoded at the end of the study.BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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Study and school staff and subjects were blind to group
assignment.
Sample size
The sample size was determined based on intent-to-treat
and to provide sufficient power to test the hypothesis that
xylitol gummy bears would reduce S. mutans/sobrinus and
Lactobacillus spp. levels in plaque by ≥ 0.75 log10 after 6
weeks of exposure. A sample size of n = 41 subjects per
group provided 80% power (2-sided, α = 0.05), where a
difference in total bacteria counts between pre- and post-
intervention was assumed to be 0.75 log10 = 5.6-fold
reduction. Assuming a loss to follow-up of 10% to 20%, a
total recruitment of 51 subjects per group (total n = 153)
was necessary to ensure adequate minimum sample size.
Gummy bears & unit-dose packaging
Both the xylitol and maltitol gummy bear snacks used in
this study were produced by Santa Cruz Nutritionals
(Santa Cruz, CA) especially for this study and are not
available in the general market. The gummy bear snacks
looked identical having the same weight (5 g/gummy
bear), size, colors (red and green) and flavor (strawberry).
They had similar texture and sweetness. Each gummy bear
was 30 × 20 × 15 mm in size (see Figure 1). Danisco
(Redhill, UK) and Santa Cruz Nutritionals (Santa Cruz,
CA, USA) provided the proprietary formulations for the
xylitol and maltitol gummy bears, respectively. Each 5 g
xylitol gummy bear piece contained 1.3 g (26%) xylitol,
2.7 g (54%) polydextrose, water and gelatin, and minus-
cule amounts (<1.5%) of citric and lactic acid, mineral oil,
carnauba wax and sucralose. Each maltitol gummy bear
contained 3.7 g (74%) maltitol, water, gelatin, and similar
minuscule amounts of the other ingredients found in xyl-
itol gummy bears. Both types of gummy bears contained
similar amounts of substances with laxative effects, i.e.
maltitol gummy bear = 3.7 g, xylitol gummy bear = 4.0 g
(1.3 g xylitol + 2.69 g polydextrose). However, polydex-
trose, a non-digestible polysaccharide, has a lower thresh-
old (~90 g/day) for side effects [9] thus the laxative effects
may have been slightly higher for the xylitol gummy bear
groups.
Study personnel pre-packaged the gummy bears in unit-
doses for classroom distribution three times a day: 15.6 g/
day = four xylitol gummy bears; 11.7 g/day = three xylitol
and one maltitol gummy bears; and maltitol control =
four maltitol gummy bears per unit-dose for a total of 12
gummy bears per day for all three groups. Unit-dose pack-
ages were labeled with the appropriate randomized ID
numbers, date, and period of distribution to facilitate
tracking of the administrations each child received per
day.
Gummy bears distribution and adherence procedures
Unit-dose packages were ordered by day and session for
each child and pre-packed into bins by classroom before
being delivered to the schools weekly. School principals
identified people who regularly served as classroom vol-
unteers to hire as community workers for the study. Those
women received training in the Responsible Conduct of
Research at the University of Washington and were
trained to distribute and monitor consumption of the
gummy bear snacks in the classroom. The community
workers established a schedule with the teachers that
allowed them to cover all classrooms three times over the
course of the school day at approximately even intervals.
The unit-dose packages were distributed according to the
child's assigned ID number, date and session number. The
community workers observed the consumption of the
gummy bears and immediately collected and recorded
any unconsumed gummy bears, including those for any
absent children. Classroom logs were faxed to the research
staff daily to monitor study progress. Incompletely con-
sumed packages of gummy bears were stored in the staff
workroom and were picked up by the research staff weekly
and checked against the classroom logs for accuracy.
Photograph of Xylitol and Maltitol Gummy Bears Figure 1
Photograph of Xylitol and Maltitol Gummy Bears.BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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To increase acceptance of the gummy bear snacks and to
permit adaptation of the gastro-intestinal system to the
polyols, the first week of the study was designed as a
ramp-up period. All groups consumed one unit-dose
(four gummy bears) corresponding to their group assign-
ment (X16, X12, or M45) on day one and gradually
increased to the full three unit-doses (12 gummy bears) by
day six. Parents were provided with information on and
encouraged to report to the community workers laxative
effects common to polyol consumption such as bloating,
stomach cramps, flatulence, loose stool, or diarrhea that
their child might experience. During the third week of the
study, parents were sent a questionnaire on their child's
side effects experiences.
Plaque sampling and culture
Trained research staff collected plaque samples from the
children at enrollment (baseline) and six weeks later.
Research staff collected samples on-site in the stage area of
the assembly hall, from one to four classrooms, through-
out the school day. No special instructions were given
regarding tooth brushing on collection day. As with our
previous xylitol dose and frequency studies, research staff
collected samples from the cervical third of the buccal sur-
faces of all teeth using one sterile Kerr applicator per arch.
The samples were placed in 5 mL tubes containing glass
beads and 1 mL of pre-reduced saline. The tubes were
stored at room temperature and transported the same day
from the schools to the laboratory by study staff. Samples
were processed the same day or within 24 hours of collec-
tion. In the laboratory, plaque was prepared in pre-
reduced saline and 10-fold dilutions were prepared sepa-
rately. For each sample, a modified Mitis Salivarius agar
(Difco Laboratories Inc., Detroit, MI, USA) supplemented
with 500 μg/mL kanamycin, 1% potassium tellurite solu-
tion, and 50 U/mL bacitracin (MSKB) was used to enu-
merate  S. mutans/sobrinus. The MSKB medium is more
specific than MSB for MS isolation [10,11] but does not
distinguish between S. mutans and S. sobrinus although a
previous study found that more than 75% of the isolates
were  S. mutans [11]. Thus, counts from MSKB plates
included both S. mutans and S. sobrinus and is denoted as
S. mutans/sobrinus in this report to clearly show which spe-
cies of MS are being referenced. Rogosa SL agar was use to
culture and enumerate the Lactobacillus spp. [12]. Freshly
prepared plates were used. The plaque samples were vor-
texed to break up the plaque and then diluted. The 10-0 to
10-3 dilutions were plated on MSKB media and incubated
in 5% CO2 at 36.5°C for five to seven days. The Rogosa SL
agar was incubated anaerobically at 36.5°C for seven days
prior to enumeration.
Statistical procedures
Descriptive statistics were used to describe the cohort. Sig-
nificance of pre- to post-intervention reductions in bacte-
ria levels within groups were assessed using paired T-tests.
The analysis of covariance (ANCOVA) was used to assess
the association between different treatment groups for
pre- and post-intervention bacterial levels. The latter was
adjusted for compliance. The SPSS (v.11.5) and SAS
(v.9.1) statistical software were used.
Results
Baseline
A total of 154 children participated in the three-arm study:
15.6 g xylitol/day (X16, n = 53); 11.7 g xylitol/day (X12,
n = 49); and 44.7 g maltitol/day, (M45, n = 52). The mean
age (standard deviation) of the children was 8.4 (1.4)
years, 55% were boys (85/154) and 90% (138/154) was
Caucasian. The mean age and racial/ethnic distribution
among the groups were similar (Table 1). At baseline, 42
children (27.3%) did not have measurable S. mutans/sobri-
nus levels (< 102 cfu/mL. X16 = 17/52, X12 = 12/49, and
M45 = 13/53) and 54 children (35.1%) did not have
measurable Lactobacillus spp. (< 102 cfu/mL, X16 = 17/52,
X12 = 19/49, and M45 = 18/53). Twenty nine (18.8%)
children had S. mutans/sobrinus levels ≥ 104 (X16 = 21.1%,
X12 = 22.4%, and M45 = 13.2%) and among these, 7
(4.5%) children had levels ≥ 106 (X16 = 2, X12 = 2, M45
= 3). The mean log10 S. mutans/sobrinus or Lactobacillus
spp. levels in plaque between the groups at baseline were
not statistically different. Excluding children who did not
have measurable S. mutans/sobrinus and Lactobacillus spp.
increased the baseline mean S. mutans/sobrinus s and Lacto-
bacillus spp. levels, respectively; however, there were still
Table 1: Descriptive statistics and gummy bear compliance by group.
Group
Maltitol
 44.7 g/day
Xylitol 
11.7 g/day
Xylitol 
15.6 g/day
Total
N 53 49 52 154
Mean Age (SD) 8.63 (1.4) 8.01 (1.3) 8.60 (1.37) 8.42 (1.38)
Male (%) 26 (49%) 31 (63%) 28 (54%) 85 (55%)
Caucasian (%) 49 (92%) 42 (86%) 47 (90%) 138 (90%)
% Missed GB (SD) 21% (24.7) 25% (28.1) 24% (26.2) 23% (26.3)BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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no significant differences in mean reduction between the
groups.
Six week follow-up
At the six week follow-up, 97% of the children completed
plaque sampling collection (X16 = 49/52, X12 = 48/49,
M45 = 52/53). Overall, children consumed 77% of the
total number of gummy bears possible for the study
period (X16 = 76.4%, X12 = 73.7%, M45 = 80.4%, Table
1). Nearly all children consumed some gummy bears at
each distribution session. However, 15% of the children
were frequently absent and consumed less than 50% of
their gummy bear allotment while several consumed less
than 10% allotted. The proportions of these children were
evenly distributed among the groups.
The hypothesis tested was whether consumption of xylitol
gummy bear snacks at the study dosages over a six-week
period, including the one week ramp-up, would reduce S.
mutans/sobrinus and Lactobacillus spp. levels in plaque. A
reduction in bacteria levels in response to maltitol expo-
sure was not expected. Results showed significant reduc-
tions in S. mutans/sobrinus levels pre- to post-intervention
for the xylitol groups as well as for the maltitol group
(group, log10 mean reduction [SD], p-value: X16, 1.13
[1.65], p < 0.0001; X12, 0.89 [1.11], p < 0.0001; and M45,
0.91 [1.46], p < 0.0001, Table 2 & Figure 2). Analysis of
the covariance (ANCOVA) showed the reductions in S.
mutans/sobrinus were not statistically different between the
three groups or when xylitol groups (X16 + X12) were
combined and compared to the maltitol group (Table 3).
Thirty-eight children changed from detectable S. mutans/
sobrinus to non-detectable levels (X16 = 13/52, X12 = 10/
49, and M45 = 15/53). Two children, one from each from
group X16 and X12, changed from non-detectable to
detectable levels.
Changes in Lactobacillus spp. levels pre- to post-interven-
tion were mixed with mean reduction (SD) observed for
groups X16 = 0.31 (2.35) log10, and M45 = 0.52 (2.41)
log10 but an increase in levels seen with X12 = 0.11 (2.26)
log10, (Table 2). However, these mean changes were not
significant and were within or near the measurement
error, 0.5 log10. Adjusting for percent of unconsumed
gummy bears did not significantly change the statistical
results for either S. mutans/sobrinus or Lactobacillus spp.
When children with no measurable S. mutans/sobrinus lev-
els at baseline (n = 42) were removed from analyses, the
mean log10 reduction (SD) for each group increased, X16
Table 2: Mean log10 S. mutans/sobrinus and Lactobacillus spp. levels and standard deviation at baseline, six weeks and the differences 
between six weeks and baseline for schoolchildren exposed to gummy bear snacks containing either xylitol (11.7 g/d or 15.6 g/d) or 
maltitol.
Group N Variable Mean Std Dev Paired T-Test
M45 (maltitol 44.7 g/d) 53
S. mutans/sobrinus Baseline 2.09 1.73
Six weeks 1.17 1.55
Six weeks – baseline -0.91 1.46 p < 0.0001
Lactobacillus spp. Baseline 2.11 1.82
Six weeks 1.63 1.92
Six weeks – baseline -0.52 2.41 p = 0.13
X12 (xylitol 11.7 g/d) 49
S. mutans/sobrinus Baseline 2.36 1.81
Six weeks 1.42 1.64
Six weeks – baseline -0.89 1.11 p < 0.0001
Lactobacillus spp. Baseline 1.79 1.86
Six weeks 1.89 1.87
Six weeks – baseline 0.11 2.26 p = 0.75
X16 (xylitol 15.6 g/d) 52
S. mutans/sobrinus Baseline 2.25 2.00
Six weeks 1.13 1.62
Six weeks – baseline -1.13 1.65
Lactobacillus spp. Baseline 2.29 1.65 p = 0.75
Six weeks 2.05 1.91
Six weeks – baseline -0.31 2.35 P = 0.36BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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= 1.74 (1.67); X12 = 1.21 (1.10); M45 = 1.22 (1.57), and
remained significant, P < 0.0001, (Table 4 & Figure 3).
Comparison of reductions between the three groups
remained non-significant.
Snack program acceptability
Post-study informal discussions were held with school
principals, teachers, and community workers. All agreed
that it was feasible to implement an in-classroom xylitol
gummy bear snacks program for caries prevention, and
that parents are accepting of the program and children are
willing to consume gummy bear snacks daily. Teachers
indicated that although challenging initially, it was possi-
ble to organize classroom activities to incorporate the
snack time, that the community workers were of tremen-
dous value in keeping the program on track and flowing,
and that the children were generally well behaved during
snack time and followed directions once they became
accustomed to the routine. Community workers enjoyed
the interaction with the teachers and children and they
liked the idea that they were contributing to a program
that could improve children's oral health.
Discussion
This study is part of a series to explore effective xylitol
delivery vehicles that can be used in school programs in
the U.S. Results from the xylitol dose study [3] showed
groups consuming 6.9 g and 10.3 g xylitol per day deliv-
ered via chewing gum had significant reductions in S.
mutans/sobrinus levels in plaque and saliva after five weeks
and six months of exposure. The smallest dose, 3.4 g/day,
showed a small but not statistically significant reduction.
However, the study did not have groups consuming doses
Mean S. mutans/sobrinus levels in plaque at baseline and six weeks of gummy bear exposure Figure 2
Mean S. mutans/sobrinus levels in plaque at baseline and six weeks of gummy bear exposure. Mean S. mutans/sobri-
nus levels in plaque at baseline and six weeks for school children exposed to in-school gummy bear snacks containing either 
xylitol (11.7 g/d or 15.6 g/d) or maltitol three times per day.
Table 3: Analysis of the Covariate (ANCOVA) comparing S. 
mutans/sobrinus and Lactobacillus spp. levels at six weeks of 
gummy bear snack exposure between groups*
Comparison Group F-value P-value
S. mutans/sobrinus
Maltitol vs. Xylitol groups combined 0.16 0.69
X16 Xylitol vs. X12 Xylitol 0.64 0.43
X16 Xylitol vs. M45 Maltitol 0.00 0.99
X12 Xylitol vs. M45 Maltitol 0.55 0.46
Lactobacillus spp.
M45 Maltitol vs. Xylitol groups combined 0.13 0.72
X16 Xylitol vs. X12 Xylitol 0.00 0.99
X16 Xylitol vs. M45 Maltitol 0.09 0.76
X12 Xylitol vs. M45 Maltitol 0.10 0.75
*Analysis of the Covariate (ANCOVA) adjusted for treatment 
assignment, baseline S. mutans/sobrinus or Lactobacillus spp. level, 
interaction term between baseline and treatment, and percent gummy 
bears missed.BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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between 3.4 g and 6.9 g per day, thus it is possible that
doses within this range would also be effective. The xylitol
frequency study [4] where the xylitol dose was kept con-
stant (10.3 g/day) and frequency varied (0, 2, 3, and 4),
showed a linear response in S. mutans/sobrinus reduction
with increasing frequency of use. However, a minimum
frequency of three administrations per day was required
for xylitol chewing gum at therapeutic dose to signifi-
cantly reduce S. mutans/sobrinus levels in plaque and saliva
after five weeks of exposure. Twice pay day use group
showed a small reduction consistent with the linear line
model but was not statistically different from the control.
These studies attempted to establish the minimum effec-
tive dose and frequency for the use of xylitol. This is
important toward establishing guidelines for effective
dose and frequency of xylitol use.
Another study in this series assessed the bioavailability of
xylitol in saliva over 15 to 20 minutes during and after
consumption of different xylitol-containing products
including: pellet (2.6 g) and stick (3 g) chewing gums,
syrup (2.7 g), and gummy bear (2.6 g) [13]. Participants
swallowed normally and at 10 to 11 specified time points,
spat into a receptacle until a minimum of 0.5 mL saliva
was collected. Xylitol concentration in saliva was meas-
ured by high performance liquid chromatography
(HPLC). The results showed similar time-curves as well as
areas under the curve for the products tested. Thus, similar
dose and frequency of xylitol consumption via these prod-
ucts would likely result in comparable S. mutans/sobrinus
reduction.
In the present study, we tested the effectiveness of gummy
bear snacks containing higher levels of xylitol in reducing
S. mutans/sobrinus and  Lactobacillus  spp. levels in chil-
dren's plaque after six weeks of exposure. The study was
designed and implemented prior to initiation of the bioa-
vailability study when uncertainty remained as to whether
different xylitol-containing products would have compa-
rable oral bioavailability. The study design controlled for
frequency and number of gummy bears consumed. A
school-based randomized controlled clinical trial cur-
rently underway is using a lower xylitol dose (7.8 g/day)
and a natural fiber (inulin) gummy bear as the control
with dental caries as an endpoint.
The results showed that six weeks of habitual xylitol
gummy bear consumption reduced the levels of S. mutans/
sobrinus in plaque compared to baseline levels (Figure 2).
A nearly one log10 mean reduction of S. mutans/sobrinus
levels in children is highly significant given that children
had lower levels of S. mutans/sobrinus infection (mean
Mean S. mutans/sobrinus levels in plaque at baseline and six weeks excluding children with non-measurable S. mutans/sobrinus  levels at baseline Figure 3
Mean S. mutans/sobrinus levels in plaque at baseline and six weeks excluding children with non-measurable S. 
mutans/sobrinus levels at baseline. Mean S. mutans/sobrinus levels in plaque at baseline and six weeks for school children 
exposed to in-school gummy bear snacks containing either xylitol (11.7 g/d or 15.6 g/d) or maltitol three times per day after 
excluding 42 children with non-measurable S. mutans/sobrinus levels at baseline.BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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baseline ~2 log10) than among adults in our previous
studies (mean baseline ~5 log10). The 15.6 g/day group
had a slightly greater reduction in S. mutans/sobrinus levels
but the difference was not significant compared to the
11.7 g/day group. This is in agreement with our dose-
response study, which suggested a plateau effect at higher
xylitol doses. Controlling for the number of unconsumed
gummy bears among the groups did not change the
results of within or across group comparisons. This sup-
ports findings from previous studies that xylitol reduces
MS [14,15]. For a review of these studies, see Maguire &
Rugg-Gunn (2003) [16]. More importantly, the results
indicate that a gummy bear snack may be an effective
method for delivering xylitol. However, these results
should be interpreted cautiously given that a significant
reduction in S. mutans/sobrinus levels was also observed
with the maltitol group. Maltitol is a member of the sugar
alcohol family that, as a class, is widely considered to be
non-cariogenic. However, aside from xylitol, studies
involving sugar alcohols, most commonly sorbitol, sug-
gest they have little effect in actively reducing MS levels.
There have been only a few studies on the association
between maltitol and MS or dental caries. In a specific
pathogen-free (SPF) Sprague-Dawley rats study, Ooshima
and colleagues reported that maltitol did not induce den-
tal caries in SPF rats infected with MS including S. mutans
MT8148R or S. sobrinus 6715 strain, and replacement of
the dietary sucrose content with maltitol resulted in a
trend towards caries reduction in SPF rats [17]. However,
a study conducted in Estonia found xylitol-maltitol and
xylitol-polydextrose candies (49% xylitol in each) were
equally effective in reducing MS suggesting that maltitol
gave no added benefit to xylitol [18]. In a more recent
study comparing xylitol (7.9 g/day) and maltitol (7.1 g/
day) chewing gum to control (no gum) consumption over
a six month period, Haresaku and colleagues reported
that xylitol significantly reduced MS levels in plaque while
maltitol increased MS levels [19]. This is clearly incongru-
ous with our findings. However, the authors acknowl-
edged several weaknesses in the study including a non-
randomized study design (participants had the option to
select their gum flavor which dictated their group assign-
ment), average age of the maltitol group was higher which
had a negative association with plaque MS levels, and
only 59% of the control group remained in the final anal-
ysis. In addition, our study used a very high maltitol dose
(44.7 g/day) 4–6 times that of previous studies, thus the
Table 4: Mean Log10 S. mutans/sobrinus and Lactobacillus spp. levels and standard deviation at baseline, six weeks and the differences 
between six weeks and baseline after excluding 42 children with non-measurable S. mutans/sobrinus levels at baseline for children 
exposed to xylitol (11.7 g/d or 15.6 g/d) or maltitol (44.7 g/day) gummy bear snack.
Group N Variable Mean Std Dev Paired T-Test
M45 (maltitol 44.7 g/d) 40
S. mutans/sobrinus Baseline 2.77 1.44
Six weeks 1.56 1.62
Six weeks – baseline -1.22 1.57 p < 0.0001
Lactobacillus spp. Baseline 2.09 1.86
Six weeks 1.83 2.03
Six weeks – baseline -0.31 2.40 p = 0.42
X12 (xylitol 11.7 g/d) 37
S. mutans/sobrinus Baseline 3.12 1.39
Six weeks 1.87 1.66
Six weeks – baseline -1.21 1.10 p < 0.0001
Lactobacillus spp. Baseline 1.96 1.86
Six weeks 1.97 1.90
Six weeks – baseline 0.01 2.39 p = 0.99
X16 (xylitol 15.6 g/d) 35
S. mutans/sobrinus Baseline 3.35 1.49
Six weeks 1.61 1.75
Six weeks – baseline -1.74 1.67 p < 0.0001
Lactobacillus spp.
Baseline 2.51 1.85
Six weeks 2.41 1.94
Six weeks – baseline -0.14 2.25 p = 0.73BMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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results cannot aptly be compared nor can a direct compar-
ison between the 15.6 or 11.7 g/day xylitol dose and the
44.7 g/day maltitol dose be made. Finally, it has been sug-
gested that high or habitual polyols consumption may
disturb polysaccharide synthesis leading to plaque and
thus MS that are more loosely bound to teeth surfaces,
consequently reducing MS levels [20]. Nevertheless, con-
flicting evidence exists and further research on the associ-
ation between maltitol, S. mutans/sobrinus, and dental
caries is needed.
The finding that S. mutans/sobrinus reductions were not
significantly different between the two xylitol groups was
not surprising as our previous dosage study in this series
suggested a plateau effect at higher therapeutic doses and
our oral bioavailability study showed similar time curves
and areas under the curve for xylitol chewing gums, syrup,
and gummy bears. The reduction observed with maltitol
was also not significantly different from the xylitol groups
individually or combined. Although a systematic error in
processing, culturing, or enumerating of S. mutans/sobri-
nus in the latter part of the study might explain the lower
levels observed in all three groups, it would be unlikely
since the reduction observed with the xylitol groups was
as expected. Furthermore, sample processing, transport,
culturing, and enumeration were carried out by protocol
as was done with the baseline samples and the research
and laboratory staff had remained unchanged, were
highly experienced, and had carried out similar protocols
in the previous studies of this series. The mechanical act of
frequent chewing of gummy bears may reduce plaque for-
mation and S. mutans/sobrinus adhesion but then Lactoba-
cillus spp. levels should be similarly affected yet that was
not observed. Lactobacillus  spp. levels remained
unchanged. Furthermore, chewing gum studies with sorb-
itol or sorbitol/maltitol gums have shown no effects on
MS plaque or saliva levels [3,21,22]. Nevertheless, the xyl-
itol results would have been strengthened if a true non-
actively anticariogenic substance such as sorbitol was used
as a control as in previous xylitol studies.
As noted earlier, 27% of the children (X16 = 32%, X12 =
24%, M45 = 25%) did not have measurable S. mutans/
sobrinus levels at baseline and may have biased the results.
Sub-analyses with these children removed showed greater
mean log10 reductions in S. mutans/sobrinus levels for all
groups (X16 = 1.74 vs. 1.13, X12 = 1.21 vs. 0.89, M45 =
1.22 vs. 0.91). There were no significant differences
between the three groups in the levels of reduction.
This study also assessed Lactobacillus spp. response to xyl-
itol exposure as the literature contains conflicting infor-
mation. Juric and colleagues reported a reduction in these
bacteria after two months of xylitol chewing gum expo-
sure [23]. The Turku sugar studies [24] and the Belize xyl-
itol study [21] with much longer follow-up periods also
reported reductions in salivary Lactobacillus spp. On the
other hand, in a study comparing the effects of chewing
xylitol (5 g/day), sorbitol, and fructose gum over a four
week period on S. mutans and Lactobacilli in plaque, Loe-
sche and colleagues reported only xylitol significantly
reduced S. mutans levels and there was no effect on the
Lactobacilli levels for any gum [14]. Similarly, a recent
study among young adults (21 to 24 years of age) reported
no change in salivary Lactobacillus spp. in response to xyl-
itol chewing gum consumption three times per day (6 g
total) over a three week period but reported a significant
reduction in salivary MS level [25]. The current study
found that neither of the xylitol groups nor the maltitol
group had an effect on Lactobacillus spp. level. It is possible
that xylitol selectively affects and reduces S. mutans/sobri-
nus  levels without altering Lactobacillus  spp. levels, the
other bacteria implicated in development of caries. Alter-
natively, the six weeks follow-up period of this study
might not have been of sufficient length to detect the
effects on Lactobacillus spp. Nevertheless, xylitol studies
with dental caries as an end-point have repeatedly shown
xylitol's effectiveness in caries reduction [26].
Finally, the post-study discussion with school principals,
teachers, and community workers suggested that it is fea-
sible to implement a school-based xylitol gummy bear
snacks program. Teachers were willing and able to incor-
porate the three times per day snack program into their
classroom curriculum with minimal disruption after a
brief adjustment period. Parents were willing to allow
their children to participate in an oral health program and
to consume gummy bear snacks at school to reduce tooth
decay. Children were willing to eat most of the gummy
bears provided at each distribution. A significant degree of
commitment, cooperation, motivation, and effort from
all parties involved was necessary to successfully imple-
ment and carry out the program. The information and
experience gained from the current study were valuable in
strategizing and developing the protocols used to imple-
ment and carry out the xylitol gummy bear snacks rand-
omized clinical trial being conducted among kindergarten
children in an elementary school district in Cleveland,
Ohio. A lower xylitol dose is being used.
This study had several limitations. Plaque collection was
not standardized by plaque weight but rather by sampling
the arches of teeth. This may be viewed as qualitative and
may affect the quantitative analysis. However, the effect is
minimized by standardization of sampling technique, by
staff training, and by the use of staff with previous experi-
ence in this sampling technique. Furthermore, our previ-
ous studies with xylitol chewing gums showed that S.
mutans/sobrinus  levels in plaque sampling at screening
were comparable to those at baseline for subjects andBMC Oral Health 2008, 8:20 http://www.biomedcentral.com/1472-6831/8/20
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throughout the study among controls. The use of the
manufacturer's (Santa Cruz Nutritionals) high dose malti-
tol (44.7 g) formula rather than the sorbitol/polydextrose
formula was necessary because the sorbitol formula
would not congeal properly to form the gummy bear dur-
ing production. The reduction observed with high dose
maltitol may have weakened our xylitol results. The inher-
ent limitations of the setting and its capacity to deliver a
public health intervention are an additional weakness. In
this study, the intervention was delivered in a school set-
ting and was subject to school closures and early dismiss-
als, children's absences and cooperation, and classroom
activities. For example, we experienced fluctuating coop-
eration of the children (e.g., some wanted to negotiate the
number of bears to be consumed on some days, some pre-
ferred a specific color). Despite these difficulties, the local
community workers who delivered the gummy bears
made valiant attempts at getting the gummy bears to the
children. Overall, 73% of the children consumed at least
75% of the total possible gummy bears distributed.
Based on our findings, it is feasible to develop and imple-
ment xylitol-based caries preventive programs in struc-
tured settings such as schools and daycare. These
structured environments offer an opportunity to achieve
xylitol frequency and dose compliance. However, imple-
menting a new activity into an institutional setting would
undoubtedly be a challenging task and require the accept-
ance and commitment of all parties within the setting
(e.g., school administration, teachers, parents and stu-
dents, etc.).
Conclusion
Xylitol gummy bear snack consumption at therapeutic
dose and frequency reduced S. mutans/sobrinus but not
Lactobacillus spp. levels in plaque after six weeks of habit-
ual exposure. Xylitol doses in the high therapeutic range
such as those in this study, 11.7 g and 15.6 g/day, pro-
duced similar reductions confirming a plateau of effect
previously reported in this series of studies. High dose
maltitol (44.7 g/day) also reduced S. mutans/sobrinus lev-
els in plaque after six weeks of exposure. It is feasible to
implement a xylitol gummy bear snack program in the
school setting or daycare. Further study is needed to con-
firm the results and help determine if implementing such
a program should be seriously considered to reduce the
burden of dental caries among U.S. children, particularly
those in high-risk populations.
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